Skip to main content
. 2015 Apr 17;29(12):3588–3593. doi: 10.1007/s00464-015-4113-1

Table 1.

The patient characteristics and treatment outcomes

Variable Mean ± SD (n, %)
No. of patients 41
Age (years) 53.95 ± 14.10
Gender (male) 13 (31.7 %)
Size of tumor (mm) 16.34 ± 5.89
Location of tumor
 Antrum anterior wall 1 (2.44 %)
 Antrum greater curvature 2 (4.88 %)
 Corpus anterior wall 6 (14.63 %)
 Corpus greater curvature 6 (14.63 %)
 Corpus lesser curvature 4 (9.76 %)
 Corpus posterior wall 9 (21.95 %)
 Fundus 13 (31.71 %)
Duration of EFTR 78.82 ± 46.44
OTSC 6 (14.63 %)
Pneumoperitonea during EFTR 26 (63.41 %)
Cost of defect closing 1014.04 ± 524.89
In-hospital days 5.39 ± 1.14
Pathology
 Carcinoid tumor 1 (2.44 %)
 GIST 33 (80.49 %)
 Heterotopic pancreas 1 (2.44 %)
 Hyaline degeneration 1 (2.44 %)
 Leiomyoma 4 (9.76)
 Schwannoma 1 (2.44 %)
 Complications 9 (21.95 %)
 Abdominal pain 2 (4.88 %)
 Dysuresia 1 (2.44 %)
 Abdominal pain and fever 3 (7.32 %)
 Nausea and vomiting 1 (2.44 %)
 Pharyngalgia 1 (2.44 %)
 Tenderness of upper abdomen 1 (2.44 %)

OTSC over-the-scope clip system, GIST gastrointestinal stromal tumor